Sprint Bioscience

Moving in to new premises

Sprint Bioscience — Wed, 25 Apr 2012 09:32:55 +0000

Spring has come to Sweden, and inspired by the migrating birds and forced by our expanding business, Sprint Bioscience moves into new premises. From 2nd of May our medicinal chemistry section will be situated at Greehouse Labs, located at KTH Royal Institute of Technology, Stockholm, Sweden.

Sprint Bioscience has further strengthened the drug discovery team

Sprint Bioscience — Wed, 28 Mar 2012 11:55:49 +0000

To advance the expanding portfolio within cancer metabolism Sprint Bioscience has recruited experienced medicinal chemist with a track record in structure based drug discovery. In addition the company is increasing the capacity within protein crystallography and cell based assays.

AACR Annual Meeting

Sprint Bioscience — Wed, 14 Mar 2012 08:01:49 +0000

Sprint Bioscience attends the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago, 31 March – 4 April. There are several interesting talks on autophagy inhibition on the agenda.

Bio-Europe spring 2012

Sprint Bioscience — Wed, 14 Mar 2012 07:47:24 +0000

Sprint Bioscience attends Bio-Europe Spring 2012 in Amsterdam, The Netherlands, 19-21 March.

BioPartnering North America

Sprint Bioscience — Thu, 02 Feb 2012 12:45:27 +0000

Sprint Bioscience attends BioPartnering North America 2012 in Vancouver, Canada, 26-28 February.

Dr. Fredrik Rahm joins Sprint Bioscience as Principal Scientist

Sprint Bioscience — Thu, 01 Dec 2011 12:07:33 +0000

Sprint Bioscience Medicinal Chemistry team is pleased to announce that Dr. Fredrik Rahm will join us from AstraZeneca in the position as Principal Scientist starting December 1. Fredrik will strengthen Sprint Bioscience by bringing several years of fragment based drug discovery experience into our team. Welcome Fredrik!

SciBX article

Sprint Bioscience — Fri, 11 Nov 2011 14:42:34 +0000

Sprint Bioscience is featured in the article in Science Business eXchange on autophagy inhibition in cancer treatment.

SciBX 4(42); doi:10.1038/scibx.2011.1166
Published online Oct. 27 2011
Taking down autophagy – Nature

World Cancer Metabolism Summit

Sprint Bioscience — Fri, 11 Nov 2011 14:35:22 +0000

The CSO of Kancera AB will give a presentation with the titel Attacking PFKFB3 Using a Structure-Based Design Approach at the World Cancer Metabolism Summit, 1-2 of February 2012, in Washington, D.C.

World Cancer Metabolism Summit

partneringNEWS™ article

Sprint Bioscience — Fri, 11 Nov 2011 14:29:43 +0000

partneringNEWS™ published an article about Sprint Bioscience and fragment-based drug discovery.

Sprint Bioscience: Kick start for drug discovery with fragment-based screening

PSDI meeting

Sprint Bioscience — Fri, 11 Nov 2011 14:16:02 +0000

Sprint Bioscience will attend the Protein Structure Determination Industry meeting 13-15 of November 2011.